The purpose of this study is to assess the safety, pharmacokinetic and activity profiles of
the ch14.18 antibody produced in cells of hamster origin (ch14.18/CHO).
Phase:
Phase 1
Details
Lead Sponsor:
St. Anna Kinderkrebsforschung
Collaborators:
Charite University, Berlin, Germany Istituto Giannina Gaslini St. Anna Children's Hospital, Vienna